Business
Jaguar Health, Inc. Reports 2020 Second Quarter Financial Results
Q2 2020 Mytesi net sales and gross sales were approximately $3.2 million and approximately $6.3 million, respectivelyReminder: Company to host investor call
About this update from Jaguar Health, Inc.
[{"type":"text","content":"Q2 2020 Mytesi net sales and gross sales were approximately $3.2 million and approximately $6.3 million, respectivelyReminder: Company to host investor call Thursday, August 13th at 8:30 a.m. Eastern regarding Q2 2020 financials & business updatesSave the Date: Company to host virtual Diarrhea Dialogues disease education event for investors and business development contacts on October 20, 2020 focused on cancer therapy-related diarrheaSAN FRANCISCO, CA / ACCESSWIRE / August 13, 2020 / Jaguar Health, Inc. (NASDAQ:JAGX) (\"Jaguar\" or the \"Company\") today reported consolidated second quarter 2020 financial results.2020 Second Quarter Company Financial Results:Mytesi Net Product Revenue: Net sales during the second quarter of 2020 were approximately $3.2 million and $1.7 million in the second quarter of 2019. This Q2 2020 result represents 186% of the same period in 2019, or an increase of $1.5 million quarter over quarter. Net sales during the first quarter of 2020 were approximately $830,000. Net sales for the second quarter of 2020 represented 378% of the first quarter of 2020, or an increase of $2.3 million quarter over quarter.Mytesi Gross Product Revenue (Non-GAAP): Gross sales during the second quarter of 2020 were approximately $6.3 million and $2.4 million in the second quarter of 2019. This Q2 2020 result represents 268% of the same period in 2019, or an increase of $3.9 million quarter over quarter. Gross sales during the first quarter of 2020 was approximately $1.3 million. Gross sales for the second quarter of 2020 represented 482% of the first quarter of 2020, or an increase of approximately $5.0 million quarter over quarter. The gross sales for Neonorm were immaterial for all periods.Total Mytesi Bottles Sold: The total Mytesi bottles sold for the second quarter of 2020 represented 104.3% of the bottles sold for the same period in 2019. The total Mytesi bottles sold for the second quarter of 2020 represented 155% of the bottles sold for the first quarter of 2020. Three Months Ended Financial Highlights June 30, (in thousands, except per share amounts) 2020 2019 $ change % change Net product revenue $3,167 $1,706 $1,461 85.6%Loss from operations $(8,451) $(10,622) $2,171 -20.4%Net loss $(9,238) $(16,721) $7,483 -44.8%Net loss attributable to common shareholders $(10,597) $(16,721) $6,124 -36.6%Net loss per share, ba...